IL137466A0 - Breast cancer resistance protein (bcrp) and the dna which encodes it - Google Patents

Breast cancer resistance protein (bcrp) and the dna which encodes it

Info

Publication number
IL137466A0
IL137466A0 IL13746699A IL13746699A IL137466A0 IL 137466 A0 IL137466 A0 IL 137466A0 IL 13746699 A IL13746699 A IL 13746699A IL 13746699 A IL13746699 A IL 13746699A IL 137466 A0 IL137466 A0 IL 137466A0
Authority
IL
Israel
Prior art keywords
breast cancer
bcrp
encodes
dna
resistance protein
Prior art date
Application number
IL13746699A
Other languages
English (en)
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22115664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL137466(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of IL137466A0 publication Critical patent/IL137466A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13746699A 1998-02-05 1999-02-05 Breast cancer resistance protein (bcrp) and the dna which encodes it IL137466A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7376398P 1998-02-05 1998-02-05
PCT/US1999/002577 WO1999040110A1 (fr) 1998-02-05 1999-02-05 Proteine de resistance aux medicaments contre le cancer du sein (bcrp) et adn codant cette proteine

Publications (1)

Publication Number Publication Date
IL137466A0 true IL137466A0 (en) 2001-07-24

Family

ID=22115664

Family Applications (4)

Application Number Title Priority Date Filing Date
IL13746699A IL137466A0 (en) 1998-02-05 1999-02-05 Breast cancer resistance protein (bcrp) and the dna which encodes it
IL137466A IL137466A (en) 1998-02-05 2000-07-24 Polynucleotides of breast cancer resistance proteins (bcrp), nucleic acids, plasmids and expression vectors encoding the same
IL177612A IL177612A (en) 1998-02-05 2006-08-21 Breast cancer resistance protein (bcrp) and methods for identifying inhibitors thereof
IL191982A IL191982A (en) 1998-02-05 2008-06-05 Antibody binding to breast cancer resistance protein (bcrp) and screening methods using the same

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL137466A IL137466A (en) 1998-02-05 2000-07-24 Polynucleotides of breast cancer resistance proteins (bcrp), nucleic acids, plasmids and expression vectors encoding the same
IL177612A IL177612A (en) 1998-02-05 2006-08-21 Breast cancer resistance protein (bcrp) and methods for identifying inhibitors thereof
IL191982A IL191982A (en) 1998-02-05 2008-06-05 Antibody binding to breast cancer resistance protein (bcrp) and screening methods using the same

Country Status (10)

Country Link
US (4) US6313277B1 (fr)
EP (1) EP1054894B2 (fr)
JP (1) JP4187412B2 (fr)
AT (1) ATE359291T1 (fr)
AU (1) AU755567B2 (fr)
CA (1) CA2319715C (fr)
DE (1) DE69935782T3 (fr)
ES (1) ES2284243T5 (fr)
IL (4) IL137466A0 (fr)
WO (1) WO1999040110A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU755567B2 (en) * 1998-02-05 2002-12-12 University Of Maryland At Baltimore Breast cancer resistance protein (BCRP) and the DNA which encodes it
US7622557B2 (en) 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
AU4214799A (en) 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
US7138493B1 (en) 1998-11-30 2006-11-21 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding cassette protein responsible for cytotoxin resistance
AU4955200A (en) 1999-05-17 2000-12-05 Cancer Research Ventures Limited A method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs
AU2001288061A1 (en) * 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
HU0100947D0 (en) * 2001-03-02 2001-05-28 Solvo Kft Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers
US20050255084A1 (en) * 2001-10-24 2005-11-17 Solvo Biotechnology Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
EP1591112A4 (fr) * 2003-02-04 2006-06-14 Yakult Honsha Kk Inhibiteur de la proteine resistant au cancer du sein
JP2006069910A (ja) * 2004-08-31 2006-03-16 Yoshiichi Sugimoto 抗癌剤耐性克服剤
EP1672365A1 (fr) * 2004-12-16 2006-06-21 Het Nederlands Kanker Instituut Moyens et procédés pour déterminer et/ou influencer le transfert cellulair
US7465788B2 (en) * 2005-01-18 2008-12-16 University Of Maryland Breast cancer resistance protein (BCRP) and antibodies thereto
KR102211189B1 (ko) 2012-09-11 2021-02-03 코닝 인코포레이티드 약물 트랜스포터 단백질(들) 및/또는 약물대사 효소(들)를 인코딩하는 유전자(들)를 일시적으로 과발현하는 소모성 냉동보존 세포
KR101561965B1 (ko) 2013-11-27 2015-10-20 한국과학기술연구원 디스코이딘 도메인 수용체 2 활성을 조절하는 물질의 동정 방법
US20220256794A1 (en) * 2019-05-08 2022-08-18 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization Terpene synthases and transporters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
US6060248A (en) * 1997-02-24 2000-05-09 Tm Technologies, Inc. Process for selecting anti-sense oligonucleotides
AU7807298A (en) * 1997-06-04 1998-12-21 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
AU755567B2 (en) * 1998-02-05 2002-12-12 University Of Maryland At Baltimore Breast cancer resistance protein (BCRP) and the DNA which encodes it
WO1999058675A2 (fr) * 1998-05-14 1999-11-18 Chiron Corporation Genes humains et produits d'expression genique v
WO2000018912A2 (fr) * 1998-09-25 2000-04-06 Bayer Aktiengesellschaft Genes et proteines de cassette de liaison avec atp, destines au diagnostic et au traitement de desordres lipidiques et maladies inflammatoires
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
AU2001288061A1 (en) 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
CA2489474A1 (fr) 2002-06-17 2003-12-24 Banyu Pharmaceutical Co., Ltd. Procede permettant de prevoir la capacite de transport d'un medicament par des polymorphismes abcg2

Also Published As

Publication number Publication date
ES2284243T5 (es) 2017-08-22
IL177612A (en) 2011-04-28
DE69935782D1 (de) 2007-05-24
IL137466A (en) 2011-04-28
US20090104199A1 (en) 2009-04-23
US7655755B2 (en) 2010-02-02
US20030036645A1 (en) 2003-02-20
US7741445B2 (en) 2010-06-22
EP1054894B2 (fr) 2016-11-09
ATE359291T1 (de) 2007-05-15
AU2761099A (en) 1999-08-23
US20050272684A1 (en) 2005-12-08
JP2002502592A (ja) 2002-01-29
WO1999040110A1 (fr) 1999-08-12
CA2319715C (fr) 2012-08-07
US6313277B1 (en) 2001-11-06
IL191982A (en) 2011-09-27
EP1054894B1 (fr) 2007-04-11
DE69935782T3 (de) 2017-01-05
CA2319715A1 (fr) 1999-08-12
ES2284243T3 (es) 2007-11-01
JP4187412B2 (ja) 2008-11-26
IL191982A0 (en) 2008-12-29
US7541437B2 (en) 2009-06-02
DE69935782T2 (de) 2007-08-16
EP1054894A4 (fr) 2002-03-13
EP1054894A1 (fr) 2000-11-29
AU755567B2 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
IL202332A0 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
AU6451798A (en) Prostate cancer-specific marker
AU2002323120A1 (en) Periostin-based diagnostic assays
WO1999033869A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
IL196509A0 (en) Antibodies directed aganist polypeptides capable of binding to ldcam, and pharmaceutical compositions comprising the same
EP2301563A3 (fr) Peptides HSP20
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
IL145689A0 (en) Methods
AU2001233917A1 (en) Bcmp-7 as marker for diagnosis of breast cancer
WO2001088137A3 (fr) Proteines du type proteine adaptatrice myd88
AU2002249221A1 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
WO2002081640A3 (fr) Gene shinc-1 et ses utilisations diagnostiques et therapeutiques
AU4157002A (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
AU2002363807A1 (en) Breast cancer associated polypeptide
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2001055209A3 (fr) Nouvelle septine humaine et utilisations
AU2002317527A1 (en) Breast Cancer Resistance Protein (BCRP) and the DNA Which Encodes It
ATE320496T1 (de) Testisspezifische, menschliche proteinase, svph1- 8
DE69939587D1 (en) Semaphorin polypeptide
IL152232A0 (en) Promoter to il-18bp, its preparation and use
DE10045123B8 (de) Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein
AU2002322404A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same